Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Trading Statement

28 Jan 2005 09:00

Flying Brands Limited28 January 2005 Flying Brands Limited Trading Statement 28 January 2005, Jersey, Flying Brands is today providing an update on tradingfor the year ended 31 December 2004. Overview The Company has enjoyed a good performance overall for the year and hasbenefited from the actions that the management has taken to improve theefficiency of the business and revitalise its brands. Christmas trading has beendifficult for the Flying Flowers brand, but the Board anticipates that theCompany will still report double-digit earnings growth for 2004 and that it willmeet market expectations, albeit at the lower end of the range. Cash generationcontinues to be very good, as does online sales growth. Business by business highlights (annual basis) Gardening Direct: Sales overall were up on the year as a result of a number ofnew initiatives, including new product lines, price reductions, an improvedcatalogue format and successful reactivation of lapsed customers, all of whichshould help drive the brand forward in 2005. Flying Flowers: The strategy in 2004 focused on re-positioning the brand as amajor player in the low cost gift arena. After a strong H1, Flying Flowers, incommon with much of the retail sector, saw more difficult trading conditions inthe run up to Christmas, despite a late sales rally. The new gift categories,however, such as pot plants and teddy bears, tested well and will be rolled outin 2005. Listen2Books: The focus in H1 was to develop the product range and improvecustomer spend. Trading was consistently buoyant through H2, culminating in astrong Christmas performance, with sales driven by a steady stream of newproduct introductions, offering CDs as an alternative format to cassettes (whereavailable), and a promising trial of video and DVD titles tailored to the tastesof our database. These will be rolled out in 2005. Benham: Although remaining highly cash generative, Benham was unable to matchthe success of 2003, despite a full H2 programme. We are developing a newproduct strategy for this brand, which, together with a successfully implementednew operating system, should propel the brand back to growth in 2005. Flying Brands intends to announce its preliminary results for the year to 31December 2004 on 11 March 2005. For further information please contact: Flying Brands Limited 01376 575 010Mark Dugdale, Chief Executive Smithfield 020 7360 4900Nick BastinGeorge Hudson Notes to editors Jersey based Flying Brands Limited (LSE: FBDU) is a leading Home Shoppingcompany. Founded in 1965, it was admitted to the Official List of the LondonStock Exchange in 1993. The Group has the following brands: • Flying Flowers, the UK's largest flowers by post brand, despatching nearly one million bouquets a year• Gardening Direct, one of the UK's largest mail order bedding plants and gardening products operations• Listen2Books, the leading mail order audio books distributor• Benham, the first day cover stamps and coins collectables specialist More information can be found at: www.flyingbrands.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th May 20257:00 amRNSChange of Name
22nd May 20252:23 pmRNSResult of AGM
2nd May 20257:29 amRNSApplication: FDA Breakthrough Therapy Designation
29th Apr 202510:49 amRNSNotice of AGM
25th Apr 20251:46 pmRNSPublication of Annual Report
11th Apr 20253:32 pmRNSPromising Preliminary Results of Phase 1 Study
18th Mar 202510:38 amRNSPlacing to raise £250,000
3rd Feb 20257:00 amRNSIB Expands Distribution with Blackford
22nd Jan 20257:00 amRNSOperations Update
10th Jan 20257:49 amRNSIB and Prism Secure First Installation
20th Nov 20247:00 amRNSImaging Biometrics Expands Distribution
19th Nov 202411:27 amRNSBoard Changes
5th Nov 20247:00 amRNSNew Patent Application and Trading Update
15th Oct 202410:28 amRNSHolding(s) in Company
14th Oct 202412:08 pmRNSHolding(s) in Company
14th Oct 202412:05 pmRNSPDMR dealing and TR1 announcement
11th Oct 202410:42 amRNSAcquisition of Interest by Braveheart
25th Jun 20249:59 amRNSIB Opens Expanded Access Program
14th Jun 20248:38 amRNSClinical Trial Updates
29th May 20243:08 pmRNSResult of AGM
23rd May 20247:00 amRNSMajor East Coast Health System Chooses IB Nimble
20th May 20247:10 amRNSSecond FDA Rare Pediatric Disease Designation
17th May 20247:00 amRNSIB Software Enhances Clinical Decision-Making
10th May 20248:15 amRNSRare Pediatric Disease Designation Granted to GaM
2nd May 202412:47 pmRNSIB Announces Expanded Access Program for GaM
29th Apr 20243:26 pmRNSPublication of Annual Report
5th Mar 20247:00 amRNSGrant of Options
1st Mar 20248:22 amRNSHolding(s) in Company
1st Mar 20248:20 amRNSHolding(s) in Company
26th Feb 20247:00 amRNSResult of Broker Option and Total Voting Rights
22nd Feb 20247:00 amRNSPlacing and Broker Option
9th Feb 202412:49 pmRNSFDA Application Update
2nd Feb 20248:39 amRNSIB awarded a $100,000 grant
22nd Jan 202410:05 amRNSHolding(s) in Company
15th Jan 20247:01 amRNSDirector Dealings and Conversion of CLNs
15th Jan 20247:00 amRNSHolding(s) in Company
10th Jan 20247:00 amRNSIB Launching an Expanded Access Program for GaM
19th Dec 20232:29 pmRNSImaging Biometrics granted FDA “Fast-Track”
5th Dec 202310:58 amRNSIQ-AI Announces Positive Interim Phase 1 Results
20th Nov 20231:42 pmRNSHolding(s) in Company
9th Nov 202311:38 amRNSDirector Dealing and Conversion of CLNs
8th Nov 202310:59 amRNSApplication for Pediatric Rare Disease Designation
6th Nov 20231:02 pmRNSHolding(s) in Company
18th Oct 20232:29 pmRNSUpdate Regarding Imaging Biometrics LLC
13th Oct 20238:55 amRNSIB Letter to Shareholders
9th Oct 20237:00 amRNSOrphan Drug Status to GaM and Total Voting Rights
3rd Oct 202311:30 amRNSHolding(s) in Company
19th Sep 20232:32 pmRNSIQ-AI shares cease trading on the OTCQB
8th Sep 20237:00 amRNSReduced Gadolinium Approach Validated'
18th Aug 202312:06 pmRNSUpdate on Collaboration Agreement with Mayo Clinic

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.